Abstract:
The sulforhodamine B (SRB) assay was used to assess the cytotoxicity of the aqueous
(AqEx) and ethanolic (AlEx) extracts, respectively, of the aerial parts of Cleome droserifolia
(Forssk.) Del. against two human cancer cell lines, breast (MCF7) and colon (HCT116)
adenocarcinoma. AqEx exhibited higher cytotoxic activity, thus its four subfractions, namely
n-hexane (HxFr), chloroform (ClFr), ethyl acetate (EtFr), and n-butanol (BuFr) fractions,
were also tested. Purifi cation of the more active ClFr and EtFr yielded nine compounds.
Six terpenoids, guai-7(11),8-diene (C1), 1-hydroxy-guai-3,10(14)-diene (C2), 18-hydroxydollabela-
8(17)-ene (C3), (24E)-stigmasta-5,8-dien-3β-ol (C4), teucladiol [1α,5β-guai-10(14)-
ene-4β,6β-diol] (C5), and buchariol (4,10-epoxy-6α-hydroxyguaiane) (C6), were isolated
from ClFr and three fl avonol glycosides, isorhamnetin-3-O-β-D-glucoside (F1), quercetin-
3`-methoxy-3-O-(4``-acetylrhamnoside)-7-O-α-rhamnoside (F2), and kaempferol-4`-methoxy-
3,7-O-dirhamnoside (F3), were isolated from EtFr. Compounds C3 and F2 are new in
nature. The isolated compounds were identifi ed using various spectroscopic methods (UV,
IR, 1H NMR,13C NMR, HMQC, HMBC, and COSY). Compounds C1, C3, F2, and F3 showed
signifi cant cytotoxic activities against the two tested cell lines comparable to those of the
anticancer drug doxorubicin®. The new compound C3 was the most active as it had the lowest
IC50 values, (1.9 0.08) and (1.6 0.09) μg/ml corresponding to 6.5 and 5.4 μM, against
MCF7 and HCT116 cells, respectively.
